Jane Wasman - 19 May 2021 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role: Director
Signature: /s/ Dolly Vance (Attorney-in-Fact)
Issuer symbol: RIGL
Transactions as of: 19 May 2021
Net transactions value: $0
Form type: 4
Filing time: 21 May 2021, 21:03:42 UTC
Next filing: 15 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RIGL	Common Stock	Award	$0	+25,000		$0.000000	25,000	19 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RIGL	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	19 May 2021	Common Stock	30,000	$3.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the reporting person's continuous service on the Company's Board of Directors.
F2	The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors.